Healthcare -
Biotechnology - NASDAQ - US
$ 0.2024
-15.7 %
$ 3.71 M
Market Cap
-0.03
P/E
Price Target
Average
1382.21%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
61.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Virpax Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for VRPX of $3 , with forecasts ranging from
a
low of
$3 to a high of $3 .
VRPX Lowest Price Target
Wall Street Target
3 USD
1382.21%
VRPX Average Price Target
Wall Street Target
3 USD
1382.21%
VRPX Highest Price Target
Wall Street Target
3 USD
1382.21%
REVENUE FORECAST
Revenue Forecast Chart VRPX
EBIT FORECAST
EBIT Forecast Chart VRPX
NET INCOME FORECAST
Net Income Chart VRPX